Transcatheter closure of patent ductus arteriosus

Past, present and future

Alban Elouen Baruteau, Sébastien Hascoët, Julien Baruteau, Younes Boudjemline, Virginie Lambert, Claude Yves Angel, Emre Belli, Jérôme Petit, Robert H. Pass

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Summary This review aims to describe the past history, present techniques and future directions in transcatheter treatment of patent ductus arteriosus (PDA). Transcatheter PDA closure is the standard of care in most cases and PDA closure is indicated in any patient with signs of left ventricular volume overload due to a ductus. In cases of left-to-right PDA with severe pulmonary arterial hypertension, closure may be performed under specific conditions. The management of clinically silent or very tiny PDAs remains highly controversial. Techniques have evolved and the transcatheter approach to PDA closure is now feasible and safe with current devices. Coils and the Amplatzer Duct Occluder are used most frequently for PDA closure worldwide, with a high occlusion rate and few complications. Transcatheter PDA closure in preterm or low-bodyweight infants remains a highly challenging procedure and further device and catheter design development is indicated before transcatheter closure is the treatment of choice in this delicate patient population. The evolution of transcatheter PDA closure from just 40 years ago with 18 F sheaths to device delivery via a 3 F sheath is remarkable and it is anticipated that further improvements will result in better safety and efficacy of transcatheter PDA closure techniques.

Original languageEnglish (US)
Pages (from-to)122-132
Number of pages11
JournalArchives of Cardiovascular Diseases
Volume107
Issue number2
DOIs
StatePublished - 2014

Fingerprint

Patent Ductus Arteriosus
Septal Occluder Device
Equipment Design
Equipment and Supplies
Standard of Care
Pulmonary Hypertension
Catheters
Safety

Keywords

  • Grown-up congenital heart disease
  • Paediatric cardiology
  • Patent ductus arteriosus
  • Percutaneous closure
  • Pulmonary hypertension

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Baruteau, A. E., Hascoët, S., Baruteau, J., Boudjemline, Y., Lambert, V., Angel, C. Y., ... Pass, R. H. (2014). Transcatheter closure of patent ductus arteriosus: Past, present and future. Archives of Cardiovascular Diseases, 107(2), 122-132. https://doi.org/10.1016/j.acvd.2014.01.008

Transcatheter closure of patent ductus arteriosus : Past, present and future. / Baruteau, Alban Elouen; Hascoët, Sébastien; Baruteau, Julien; Boudjemline, Younes; Lambert, Virginie; Angel, Claude Yves; Belli, Emre; Petit, Jérôme; Pass, Robert H.

In: Archives of Cardiovascular Diseases, Vol. 107, No. 2, 2014, p. 122-132.

Research output: Contribution to journalArticle

Baruteau, AE, Hascoët, S, Baruteau, J, Boudjemline, Y, Lambert, V, Angel, CY, Belli, E, Petit, J & Pass, RH 2014, 'Transcatheter closure of patent ductus arteriosus: Past, present and future', Archives of Cardiovascular Diseases, vol. 107, no. 2, pp. 122-132. https://doi.org/10.1016/j.acvd.2014.01.008
Baruteau AE, Hascoët S, Baruteau J, Boudjemline Y, Lambert V, Angel CY et al. Transcatheter closure of patent ductus arteriosus: Past, present and future. Archives of Cardiovascular Diseases. 2014;107(2):122-132. https://doi.org/10.1016/j.acvd.2014.01.008
Baruteau, Alban Elouen ; Hascoët, Sébastien ; Baruteau, Julien ; Boudjemline, Younes ; Lambert, Virginie ; Angel, Claude Yves ; Belli, Emre ; Petit, Jérôme ; Pass, Robert H. / Transcatheter closure of patent ductus arteriosus : Past, present and future. In: Archives of Cardiovascular Diseases. 2014 ; Vol. 107, No. 2. pp. 122-132.
@article{a88540fbf2be490b80048d800a4c9b31,
title = "Transcatheter closure of patent ductus arteriosus: Past, present and future",
abstract = "Summary This review aims to describe the past history, present techniques and future directions in transcatheter treatment of patent ductus arteriosus (PDA). Transcatheter PDA closure is the standard of care in most cases and PDA closure is indicated in any patient with signs of left ventricular volume overload due to a ductus. In cases of left-to-right PDA with severe pulmonary arterial hypertension, closure may be performed under specific conditions. The management of clinically silent or very tiny PDAs remains highly controversial. Techniques have evolved and the transcatheter approach to PDA closure is now feasible and safe with current devices. Coils and the Amplatzer Duct Occluder are used most frequently for PDA closure worldwide, with a high occlusion rate and few complications. Transcatheter PDA closure in preterm or low-bodyweight infants remains a highly challenging procedure and further device and catheter design development is indicated before transcatheter closure is the treatment of choice in this delicate patient population. The evolution of transcatheter PDA closure from just 40 years ago with 18 F sheaths to device delivery via a 3 F sheath is remarkable and it is anticipated that further improvements will result in better safety and efficacy of transcatheter PDA closure techniques.",
keywords = "Grown-up congenital heart disease, Paediatric cardiology, Patent ductus arteriosus, Percutaneous closure, Pulmonary hypertension",
author = "Baruteau, {Alban Elouen} and S{\'e}bastien Hasco{\"e}t and Julien Baruteau and Younes Boudjemline and Virginie Lambert and Angel, {Claude Yves} and Emre Belli and J{\'e}r{\^o}me Petit and Pass, {Robert H.}",
year = "2014",
doi = "10.1016/j.acvd.2014.01.008",
language = "English (US)",
volume = "107",
pages = "122--132",
journal = "Archives of Cardiovascular Diseases",
issn = "1875-2136",
publisher = "Elsevier Masson",
number = "2",

}

TY - JOUR

T1 - Transcatheter closure of patent ductus arteriosus

T2 - Past, present and future

AU - Baruteau, Alban Elouen

AU - Hascoët, Sébastien

AU - Baruteau, Julien

AU - Boudjemline, Younes

AU - Lambert, Virginie

AU - Angel, Claude Yves

AU - Belli, Emre

AU - Petit, Jérôme

AU - Pass, Robert H.

PY - 2014

Y1 - 2014

N2 - Summary This review aims to describe the past history, present techniques and future directions in transcatheter treatment of patent ductus arteriosus (PDA). Transcatheter PDA closure is the standard of care in most cases and PDA closure is indicated in any patient with signs of left ventricular volume overload due to a ductus. In cases of left-to-right PDA with severe pulmonary arterial hypertension, closure may be performed under specific conditions. The management of clinically silent or very tiny PDAs remains highly controversial. Techniques have evolved and the transcatheter approach to PDA closure is now feasible and safe with current devices. Coils and the Amplatzer Duct Occluder are used most frequently for PDA closure worldwide, with a high occlusion rate and few complications. Transcatheter PDA closure in preterm or low-bodyweight infants remains a highly challenging procedure and further device and catheter design development is indicated before transcatheter closure is the treatment of choice in this delicate patient population. The evolution of transcatheter PDA closure from just 40 years ago with 18 F sheaths to device delivery via a 3 F sheath is remarkable and it is anticipated that further improvements will result in better safety and efficacy of transcatheter PDA closure techniques.

AB - Summary This review aims to describe the past history, present techniques and future directions in transcatheter treatment of patent ductus arteriosus (PDA). Transcatheter PDA closure is the standard of care in most cases and PDA closure is indicated in any patient with signs of left ventricular volume overload due to a ductus. In cases of left-to-right PDA with severe pulmonary arterial hypertension, closure may be performed under specific conditions. The management of clinically silent or very tiny PDAs remains highly controversial. Techniques have evolved and the transcatheter approach to PDA closure is now feasible and safe with current devices. Coils and the Amplatzer Duct Occluder are used most frequently for PDA closure worldwide, with a high occlusion rate and few complications. Transcatheter PDA closure in preterm or low-bodyweight infants remains a highly challenging procedure and further device and catheter design development is indicated before transcatheter closure is the treatment of choice in this delicate patient population. The evolution of transcatheter PDA closure from just 40 years ago with 18 F sheaths to device delivery via a 3 F sheath is remarkable and it is anticipated that further improvements will result in better safety and efficacy of transcatheter PDA closure techniques.

KW - Grown-up congenital heart disease

KW - Paediatric cardiology

KW - Patent ductus arteriosus

KW - Percutaneous closure

KW - Pulmonary hypertension

UR - http://www.scopus.com/inward/record.url?scp=84896133896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896133896&partnerID=8YFLogxK

U2 - 10.1016/j.acvd.2014.01.008

DO - 10.1016/j.acvd.2014.01.008

M3 - Article

VL - 107

SP - 122

EP - 132

JO - Archives of Cardiovascular Diseases

JF - Archives of Cardiovascular Diseases

SN - 1875-2136

IS - 2

ER -